Recent trends in antibody-based oncologic imaging
- 20 October 2011
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 315 (2), 97-111
- https://doi.org/10.1016/j.canlet.2011.10.017
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Radiolabeled Affibody−Albumin Bioconjugates for HER2-Positive Cancer TargetingBioconjugate Chemistry, 2011
- Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-d-GEEEKNuclear Medicine and Biology, 2009
- Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flowJournal of Controlled Release, 2009
- Cys-diabody Quantum Dot Conjugates (ImmunoQdots) for Cancer Marker DetectionBioconjugate Chemistry, 2009
- 124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Fluorophore−Quencher Based Activatable Targeted Optical Probes for Detecting in Vivo Cancer MetastasesMolecular Pharmaceutics, 2009
- Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and ImagingSmall, 2009
- PAMAM dendrimer‐based contrast agents for MR imaging of Her‐2/neu receptors by a three‐step pretargeting approachMagnetic Resonance in Medicine, 2008
- Optical Imaging of the Adoptive Transfer of Human Endothelial Cells in Mice Using Anti-Human CD31 Monoclonal AntibodyPharmaceutical Research, 2007
- Cancer imaging and therapy with bispecific antibody pretargetingUpdate on Cancer Therapeutics, 2007